ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,818.60
0.64%
S&P ASX All Technology
3,093.40
0.82%
Brent Oil
78.605
0.06%
US Dollar vs AUD
1.49927
-0.21%
Bitcoin
71,033.15
-0.06%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. NanoVibronix Inc (NAOV)

  7. NanoVibronix Inc (NAOV) News

NAOV NanoVibronix Inc

0.829
0.039 (4.94%)
06 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
NanoVibronix Inc NAOV NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.039 4.94% 0.829 09:58:52
Open Price Low Price High Price Close Price Previous Close
0.85 0.7319 0.85 0.829 0.79
more quote information »

Recent News

Date Time Source Heading
22/5/202422:30BWNanoVibronix Announces Commencement of UroShield Clinical..
17/5/202406:05EDGAR2Form 8-K - Current report
16/5/202422:30BWNanoVibronix Issues Letter to Stockholders
16/5/202403:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:30BWNanoVibronix Announces Distribution Agreement with VA..
01/5/202422:00BWNanoVibronix Announces PainShield Will Be Included in..
09/4/202422:30BWNanoVibronix Issues Letter to Stockholders
28/3/202423:30BWNanoVibronix Signs Agreement for Research and Development of..
27/2/202409:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202411:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202411:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202411:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202411:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202407:45EDGAR2Form SC 13G - Statement of acquisition of beneficial..
18/1/202408:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/1/202408:30EDGAR2Form 8-K - Current report
12/12/202308:30EDGAR2Form 8-K - Current report
07/12/202308:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202301:00BWNanoVibronix Featured in Your Bladder Health Magazine
05/12/202312:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202312:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202312:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202312:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202308:45EDGAR2Form 8-K - Current report
05/12/202301:00BWNanoVibronix Enters into Letter of Intent with APOGEPHA..
29/11/202301:00EDGAR2Form 8-K - Current report
29/11/202301:00BWNanoVibronix Announces Agreement for Clinical Study of..
22/11/202300:30EDGAR2Form 8-K - Current report
22/11/202300:30BWNanoVibronix Regains Nasdaq Compliance
15/11/202300:30BWNanoVibronix Issues Letter to Shareholders
14/11/202308:44EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202300:30EDGAR2Form 8-K - Current report
08/11/202300:30BWNanoVibronix UroShield Products Available on NHS Drug Tariff..
27/9/202322:00EDGAR2Form 8-K - Current report
27/9/202322:00BWNanoVibronix Gains Approval for Inclusion of UroShield..
22/9/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
22/9/202300:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
22/9/202300:25EDGAR2Form RW - Registration Withdrawal Request
13/9/202306:15EDGAR2Form S-3 - Registration statement under Securities Act of..
06/9/202322:30EDGAR2Form 8-K - Current report
06/9/202322:30BWNanoVibronix Announces Presentation of Positive Independent..
02/9/202306:30EDGAR2Form 8-K - Current report
31/8/202304:29BWNanoVibronix Announces $5 Million Private Placement Priced..
30/8/202322:30EDGAR2Form 8-K - Current report
30/8/202322:30BWNanoVibronix Cites Positive Results from Independent Testing..
30/8/202306:05EDGAR2Form 8-K - Current report
30/8/202306:05BWNanoVibronix Responds to CMS’ Determination for PainShield
28/8/202322:30EDGAR2Form 8-K - Current report
28/8/202322:30BWNanoVibronix Applies for Inclusion of UroShield Products in..
24/8/202306:45EDGAR2Form 8-K - Current report

Your Recent History

NASDAQ
NAOV
NanoVibronix
BIT
P1ZMV9
NLBNPIT1ZMV9 20241220 45
BIT
EMSA
Exchange Traded
USOTC
YEWB
Yew Bio Pharm (CE)
COIN
EPTKEUR
BIT
P1S2F6
NLBNPIT1S2F6 20240621 250
EU
BPCFK
BPCE Bpceegzc14apr28
LSE
TMG
The Mission
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved